ABN AMRO Bank N.V. Makes New Investment in Zoetis Inc. $ZTS

ABN AMRO Bank N.V. acquired a new stake in Zoetis Inc. (NYSE:ZTS) in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 319,715 shares of the company’s stock, valued at approximately $50,125,000. ABN AMRO Bank N.V. owned 0.07% of Zoetis at the end of the most recent quarter.

Several other hedge funds also recently made changes to their positions in the company. Savvy Advisors Inc. grew its position in Zoetis by 54.0% during the second quarter. Savvy Advisors Inc. now owns 3,177 shares of the company’s stock valued at $495,000 after acquiring an additional 1,114 shares during the period. Sound Income Strategies LLC grew its holdings in Zoetis by 54.3% during the 2nd quarter. Sound Income Strategies LLC now owns 432 shares of the company’s stock worth $67,000 after acquiring an additional 152 shares in the last quarter. Canoe Financial LP lifted its holdings in Zoetis by 859.0% during the 2nd quarter. Canoe Financial LP now owns 13,369 shares of the company’s stock worth $2,085,000 after buying an additional 11,975 shares during the last quarter. Strs Ohio acquired a new position in shares of Zoetis in the 1st quarter valued at about $22,891,000. Finally, Chicago Partners Investment Group LLC raised its position in shares of Zoetis by 67.0% during the 2nd quarter. Chicago Partners Investment Group LLC now owns 4,886 shares of the company’s stock worth $750,000 after purchasing an additional 1,961 shares during the period. Institutional investors and hedge funds own 92.80% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on the company. Morgan Stanley decreased their price target on Zoetis from $211.00 to $175.00 and set an “overweight” rating for the company in a research note on Monday, November 10th. Piper Sandler lifted their target price on shares of Zoetis from $210.00 to $215.00 and gave the stock an “overweight” rating in a research report on Monday, August 11th. BTIG Research reduced their price target on shares of Zoetis from $200.00 to $160.00 and set a “buy” rating for the company in a research report on Wednesday, November 12th. Argus reiterated a “buy” rating and set a $190.00 price target on shares of Zoetis in a report on Tuesday, September 9th. Finally, Stifel Nicolaus decreased their price target on Zoetis from $140.00 to $130.00 and set a “hold” rating for the company in a research note on Tuesday. Six equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $178.89.

Zoetis Price Performance

Zoetis stock opened at $115.86 on Friday. Zoetis Inc. has a 1 year low of $115.25 and a 1 year high of $181.85. The company has a current ratio of 1.76, a quick ratio of 1.04 and a debt-to-equity ratio of 1.05. The firm has a market capitalization of $51.06 billion, a P/E ratio of 19.94, a PEG ratio of 2.31 and a beta of 0.90. The business has a 50-day moving average of $138.28 and a 200-day moving average of $150.42.

Zoetis (NYSE:ZTS) last announced its quarterly earnings data on Tuesday, November 4th. The company reported $1.70 EPS for the quarter, topping analysts’ consensus estimates of $1.62 by $0.08. The business had revenue of $2.40 billion for the quarter, compared to analyst estimates of $2.42 billion. Zoetis had a net margin of 27.83% and a return on equity of 56.90%. During the same quarter in the previous year, the firm posted $1.58 earnings per share. The firm’s revenue for the quarter was up .5% on a year-over-year basis. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. On average, equities analysts anticipate that Zoetis Inc. will post 6.07 EPS for the current year.

Zoetis Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 2nd. Investors of record on Friday, October 31st will be paid a $0.50 dividend. The ex-dividend date of this dividend is Friday, October 31st. This represents a $2.00 annualized dividend and a yield of 1.7%. Zoetis’s dividend payout ratio is presently 33.67%.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.